Drug Made From Cannabis Plant Gets Backing From FDA Staff
05/22/2018 |
The treatment, which GW Pharma hopes to market under the name Epidiolex, is produced in the U.K. from a plant that has been bred to have a high cannabidiol, or CBD, content, Chief Executive Officer Justin Gover said in an interview earlier this month. The chemical is purified and made into a strawberry-flavored oral solution, he said.
gw pharm, Epidiolex, seizure, FDA |
Epidiolex, A Marijuna-Based Drug, Aces First Phase 3 Clinical Trial: Shown To Help Children With Rare Seizure Disorder
03/15/2016 |
By study’s end, the Epidiolex group had a median 39 percent reduction in the number of convulsive seizures in a month, while the placebo group had a 13 percent reduction. It was a difference the researchers called highly statistically significant.
Epidiolex, however, would be the first proposed drug made solely from cannabidiol, the plant’s second major chemical component, though one that’s steadily being bred out of existence in commercial stocks.
Ten patients, or 16 percent, experienced more severe side effects, and 8 patients decided to stop using the treatment altogether, compared to one in the placebo group. Overall, though, 84 percent of patients who experienced adverse events rated them mild or moderate.
Epidiolex, seizure |
Click here to Print the Page
